Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Implications for Cancer Therapy

Pharmacogenomics and Personalized Medicine - New Zealand
doi 10.2147/pgpm.s18861
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Phase Ii Drug Metabolizing Enzymes

Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
BiochemistryMedicineGeneticsMolecular Biology
2010English

PPARs, RXRs, and Drug-Metabolizing Enzymes

PPAR Research
Drug DiscoveryPharmacology
2009English

Drug-Induced Hepatitis and Inactivation of Drug-Metabolizing Enzymes

Drug Metabolism and Pharmacokinetics
1998English

Pharmacogenomics: Activating Cancer Drug Discovery

Environmental Health Perspectives
MutagenesisPublic HealthEnvironmentalHealthToxicologyOccupational Health
2004English

Regional Expression Levels of Drug Transporters and Metabolizing Enzymes Along the Pig and Human Intestinal Tract and Comparison With Caco-2 Cells

Drug Metabolism and Disposition
PharmacologyPharmaceutical Science
2017English

Pharmacogenetics, Pharmacogenomics and Population Admixture: Implications for Drug Development and Prescription

Nature Reviews Genetics
GeneticsMolecular Biology
2005English

Effect of Diclofenac and Naproxen on Drug-Metabolizing Enzymes in Mice.

Journal of Clinical Biochemistry and Nutrition
MedicineNutritionClinical BiochemistryDietetics
1997English

Functional Analysis of Drug Metabolizing Enzymes Using Gene Knockout Animals

Yakugaku Zasshi
PharmacologyPharmaceutical Science
2003English

Dynamics of the Localization of Drug Metabolizing Enzymes in Tissues and Cells

Biochemical Society Transactions
Biochemistry
1984English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy